PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology

Gene fusions are clinically relevant oncogenic drivers and therapeutic targets across multiple solid tumors. RSPO3 rearrangements have been described primarily in colorectal carcinoma and traditional serrated adenoma of the colorectum and have only rarely been reported in cholangiocarcinoma. Here, we describe a patient with perihilar cholangiocarcinoma (pCCA), Bismuth–Corlette type IV, with imaging findings suspicious for advanced/metastatic disease, harboring a PTPRK::RSPO3 fusion, together with ERBB2 p.S310F and TP53 p.I195T mutations, identified by next-generation sequencing (NGS) performed on a brush cytology specimen obtained from the primary biliary stricture during endoscopic retrograde cholangiopancreatography (ERCP). Fluorescence in situ hybridization (FISH) confirmed an RSPO3 rearrangement consistent with the NGS-identified PTPRK::RSPO3 fusion. RSPO3 fusions are known to enhance ligand-dependent WNT/β-catenin signaling in other tumor contexts, although the functional consequences of this alteration were not directly assessed in the index tumor. Exploratory analysis of RSPO3-associated transcriptional programs in a public pCCA cohort identified associations between higher RSPO3 expression and distinct transcriptional programs, most notably epithelial–mesenchymal transition (EMT), as well as global and TCF-dependent WNT signaling. These findings provide broader biological context for the molecular alteration but do not establish fusion-driven pathway activation. Together, these findings provide a case with PTPRK::RSPO3 fusion in pCCA, expand the spectrum of RSPO3 rearrangements described in biliary tract malignancies, and highlight the need for further investigation into their biological and potential therapeutic relevance.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210417
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology

Luis Antonio Corchete, M.M. Abad-Hernández, Diego Requena López, Juan Carlos Montero et al.
International Journal of Molecular Sciences
Cholangiocarcinoma and Gallbladder Cancer Studies
article

PTPRK::RSPO3 Fusion in Perihilar Cholangiocarcinoma: A Rare Case with Molecular Characterization and Potential Relevance for Precision Oncology

Luis Antonio Corchete, M.M. Abad-Hernández, Diego Requena López, Juan Carlos Montero, José María Sayagués, Diego Bueno-Sacristán, María Teresa Alonso-Márquez, Estefania Moyano-Sanz
article en

Abstract

Gene fusions are clinically relevant oncogenic drivers and therapeutic targets across multiple solid tumors. RSPO3 rearrangements have been described primarily in colorectal carcinoma and traditional serrated adenoma of the colorectum and have only rarely been reported in cholangiocarcinoma. Here, we describe a patient with perihilar cholangiocarcinoma (pCCA), Bismuth–Corlette type IV, with imaging findings suspicious for advanced/metastatic disease, harboring a PTPRK::RSPO3 fusion, together with ERBB2 p.S310F and TP53 p.I195T mutations, identified by next-generation sequencing (NGS) performed on a brush cytology specimen obtained from the primary biliary stricture during endoscopic retrograde cholangiopancreatography (ERCP). Fluorescence in situ hybridization (FISH) confirmed an RSPO3 rearrangement consistent with the NGS-identified PTPRK::RSPO3 fusion. RSPO3 fusions are known to enhance ligand-dependent WNT/β-catenin signaling in other tumor contexts, although the functional consequences of this alteration were not directly assessed in the index tumor. Exploratory analysis of RSPO3-associated transcriptional programs in a public pCCA cohort identified associations between higher RSPO3 expression and distinct transcriptional programs, most notably epithelial–mesenchymal transition (EMT), as well as global and TCF-dependent WNT signaling. These findings provide broader biological context for the molecular alteration but do not establish fusion-driven pathway activation. Together, these findings provide a case with PTPRK::RSPO3 fusion in pCCA, expand the spectrum of RSPO3 rearrangements described in biliary tract malignancies, and highlight the need for further investigation into their biological and potential therapeutic relevance.

International Journal of Molecular SciencesVol. 27(22)
Broad Institute (US), Harvard University (US), Universidad de Salamanca (ES), Massachusetts General Hospital (US), Hospital Virgen de la Concha (ES), Instituto de Investigación Biomédica de Salamanca (ES), Centro de Investigación Biomédica en Red de Cáncer (ES)
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon